The School of Clinical Medicine has been selected by Health Education England as a preferred provider for a Masters programme in Genomic Medicine. The establishment of a number of similar courses across the UK is part of the vision of the HEE Genomics Programme, which involves £25m over the next three years for workforce development, and includes training programmes and raising awareness.
The award of preferred provider status follows on from the announcement, in December 2014, that a CUHP-led partnership of a number of institutions and NHS Trusts across the East of England and East Midlands regions, has been chosen as one of eleven national designated Genomic Medicine Centres.
A cross-institutional team to deliver the masters programme is led by Professor Eamonn Maher, Head of the Department of Medical Genetics, and comprises colleagues from the Clinical School, CUH, the School of Biological Sciences, the Wellcome Trust Sanger Institute, the European Bioinformatics Institute, and the University’s Institute of Continuing Education (ICE)
The modular course is designed to educate and prepare students, including a range of NHS professionals, for the future adoption of genomic technologies and the increasing use of genomic information as part of the diagnostic and treatment pathway. The programme will include a one-year full-time MPhil, a two-year part-time Master of Studies MSt, and tailored CPD, Certificate or Diploma options.